The European institutions (European Commission and Council, and the EMCDDA) and member states have broadly been a progressive and civilizing factor in pushing for balanced, evidence based and humane drug policies and programmes. A multiannual EU Drugs Strategy 2013-2020 sets out the objectives and actions for EU countries and the Commission on drugs.

  • Evaluation of Dutch Drug Policy

    English summary
    Margriet Van Laar (Trimbos-instituut) & Marianne van Ooyen-Houben (WODC) eds.
    Trimbos-instituut (Utrecht) / WODC (The Hague)
    June 2009

    The main purpose of this evaluation was to determine to what extent the principal goal of Dutch drug policy has been achieved, as stated in the 1995 Policy Document on Drugs (Drugsnota). This asserts the primacy of protecting public health, and thus gives priority to drugs prevention and to the management of the individual and social risks that arise from drug use.

    application-pdfDownload the summary (PDF)

    READ MORE...
  • Global Illicit Drug Markets 1998-2007

    Peter Reuter (RAND) and Franz Trautmann (Trimbos Institute) (eds.)
    European Commission
    March 2009

    This report commissioned by the European Commission, found no evidence that the global drug problem has been reduced during the period from 1998 to 2007 – the primary target of the 1998 UNGASS, which aimed to significantly reduce the global illicit drugs problem by 2008 through international cooperation and measures in the field of drug supply and drug demand reduction. Broadly speaking the situation has improved a little in some of the richer countries, while for others it worsened, and for some of those it worsened sharply and substantially', among which are a few large developing or transitional countries. Given the limitations of the data, a fair judgment is that the problem became somewhat more severe.

    application-pdfDownload the report (PDF)

    READ MORE...

Page 2 of 2